The Indinavir Derivate as a Novel Pharmacophore for Treatment of HTLV-1 Viral Infections
Masoud Youssefi(Mashhad University of Medical Sciences), Masoud Keikha(Iranshahr University), Mohsen Karbalaei(University of Jiroft), Carlos Brites(Universidade Federal da Bahia), Kiarash Ghazvini(Mashhad University of Medical Sciences)
Iranian Journal of Virology
June 10, 2019
Cited by 1
Related Papers
<i>Pichia pastoris</i>: A highly successful expression system for optimal synthesis of heterologous proteins
|Journal of Cellular Physiology|2020|742
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
|New England Journal of Medicine|2024|260
Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design
|Microbial Pathogenesis|2017|150
Probiotics function and modulation of the immune system in allergic diseases
|Allergologia et Immunopathologia|2020|146
A global treatments for coronaviruses including COVID‐19
|Journal of Cellular Physiology|2020|124